| 产品描述: | KEA1-97 is a selective Thioredoxin-caspase 3 interaction disruptor (IC50=10 μM). KEA1-97 disrupts the interaction of thioredoxin with caspase 3, activates caspases, and induces apoptosis without affecting thioredoxin activity |
| 靶点: |
Caspase 3:10 μM (IC50);Thioredoxin:10 μM (IC50);Apoptosis; Others; Caspase |
| 体外研究: |
KEA1-97 (100 μM; 231MFP cells) impaires thioredoxin pulldown of caspase 3. KEA1-97 (10 μM; 48 hours; 231MFP cells) impaires 231MFP serum-free cell proliferation. KEA1-97 (10 μM; 0~12 hours; 231MFP cells) activates caspase 3/7 and induces apoptotic cell death. KEA1-97 (231MFP cells) resistants to survival and proliferation impairments. Western Blot Analysis Cell Line: 231MFP cells Concentration: 100 μM Incubation Time: Result: Impaired thioredoxin pulldown of caspase 3. Cell Proliferation Assay Cell Line: 231MFP cells Concentration: 10 μM Incubation Time: 48 h Result: Impaired 231MFP serum-free cell proliferation. Apoptosis Analysis Cell Line: 231MFP cells Concentration: 10 μM Incubation Time: 0~12 h Result: Activated caspase 3/7 and induced apoptotic cell death. |
| 体内研究: |
KEA1-97 (5 mg/kg; i.p.; 50 days) attenuates tumor xenograft growth. Animal Model: Immune-deficient SCID mice Dosage: 5 mg/kg Administration: I.p.; 50 days Result: Attenuated tumor xenograft growth. |
| 参考文献: |
1. Anderson KE, To M, Olzmann JA, Nomura DK. Chemoproteomics-Enabled Covalent Ligand Screening Reveals a Thioredoxin-Caspase 3 Interaction Disruptor That Impairs Breast Cancer Pathogenicity. ACS Chem Biol. 2017 Oct 20;12(10):2522-2528. doi: 10.1021/acschembio.7b00711. Epub 2017 Sep 13. PubMed PMID: 28892616. |
| 溶解性: |
Soluble in DMSO |
| 保存条件: |
-20℃ |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
0 ml |
0 ml |
0 ml |
| 5 mM |
0 ml |
0 ml |
0 ml |
| 10 mM |
0 ml |
0 ml |
0 ml |
| 50 mM |
0 ml |
0 ml |
0 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |